| 產(chǎn)品名稱 |
NCI-H2107 [H2107] |
| 商品貨號 |
B184316 |
| Organism |
Homo sapiens, human |
| Tissue |
lung; derived from metastatic site: bone marrow |
| Product Format |
flask |
| Morphology |
epithelial |
| Culture Properties |
clusters in suspension |
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease |
stage E, carcinoma; small cell lung cancer |
| Age |
36 years |
| Gender |
male |
| Ethnicity |
Black |
| Clinical Data |
male
Black
36 years |
| Complete Growth Medium |
HITES medium supplemented with 5% fetal bovine serum
The base medium for this cell line is ATCC-formulated DMEM:F12 Medium Catalog No.30-2006. To make the complete growth medium,add the following components to the base medium- 0.005 mg/ml Insulin
- 0.01 mg/ml Transferrin
- 30nM Sodium selenite (final conc.)
- 10 nM Hydrocortisone (final conc.)
- 10 nM beta-estradiol (final conc.)
- extra 2mM L-glutamine (for final conc. of 4.5 mM)
- 5% fetal bovine serum (final conc.)
|
| Cryopreservation |
Freeze medium: Culture medium, 95%; DMSO, 5%
Storage temperature: liquid nitrogen vapor phase |
| Culture Conditions |
Temperature: 37°C |
| STR Profile |
Amelogenin: X,Y
CSF1PO: 11
D13S317: 12,13
D16S539: 10,13
D5S818: 14
D7S820: 8
THO1: 6,7
TPOX: 10,11
vWA: 17 |
| Name of Depositor |
AF Gazdar, JD Minna |
| Deposited As |
Homo sapiens |
| Year of Origin |
December, 1988 |
| References |
26 pack years
NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.
|
